Table 4 Univariate and multivariate survival analyses of overall survival in high-risk group (n=71)

Age

0.049

1.059 (1.000-1.120)

0.063

1.032 (0.970-1.098)

Sex

0.760

1.236 (0.318-4.802)

Smoking

0.476

1.585 (0.446-5.626)

Drinking

0.791

0.832 (0.214-3.229)

Family history of cancer

0.611

0.703 (0.181-2.730)

T classification

0.924

1.301 (1.002-1.425)

N classification

0.944

1.560 (0.700-1.998)

UICC stage

0.179

1.896 (0.536-2.313)

Distant metastases

0.076

1.145 (0.886-1.160)

Lymphocyte count

0.612

0.683 (0.156-2.988)

CD3+ %

0.010

0.951 (0.915-0.988)

0.097

0.965 (0.872-1.068)

CD3+ count

0.140

0.282 (0.052-1.515)

CD3+CD4+ %

0.331

0.974 (0.924-1.027)

CD3+CD4+ count

0.216

0.170 (0.010-2.803)

CD3+CD8+ %

0.039

0.902 (0.818-0.995)

0.034

0.917 (0.810-1.038)

CD3+CD8+ count

0.143

0.048 (0.001-2.805)

CD4/CD8 ratio

0.353

1.467 (0.654-3.291)

CD3-CD56+ %

0.011

1.045 (1.010-1.081)

0.195

0.999 (0.919-1.086)

CD3-CD56+ count

0.115

2.196 (0.583-4.954)

CD3-CD19+ %

0.993

0.999 (0.907-1.101)

CD3-CD19+ count

0.458

0.007 (0.009-1.510)

CD3+CD56+ %

0.096

0.653 (0.395-1.079)

CD3+CD56+ count

0.185

0.702 (0.053-1.256)

CD4+CD45RA+ %

0.173

0.910 (0.794-1.042)

CD4+CD45RA+ count

0.131

0.430 (0.260-1.692)

CD4+CD45RA- %

0.564

0.978 (0.905-1.056)

CD4+CD45RA- count

0.251

0.668 (0.071-3.681)

CD4+CD45RA+/CD4+CD45RA- ratio

0.218

0.149 (0.007-3.079)

CD4+CD45RO+ %

0.328

0.960 (0.885-1.042)

CD4+CD45RO+ count

0.251

0.068 (0.001-6.681)

CD8+CD38+ %

0.748

1.021 (0.901-1.157)

CD8+CD38+ count

0.804

0.309 (0.043-2.341)

WBC count

0.836

1.037 (0.733-1.468)

Neutrophil count

0.795

1.051 (0.725-1.523)

NLR

0.584

1.047 (0.889-1.232)

Monocyte count

0.513

2.454 (0.167-3.111)

LMR

0.173

0.718 (0.446-1.156)

Platelet count

0.432

1.002 (0.997-1.006)

PLR

0.439

1.001 (0.999-1.003)

SII

0.276

1.000 (1.000-1.001)

LDH

0.887

0.998 (0.971-1.026)

LDH

0.497

0.994 (0.978-1.011)